Clinical Trial: Domperidone in Refractory Gastroparesis

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: Domperidone in Refractory Gastroparesis

Brief Summary: The primary objective of this study is to prescribe oral domperidone for patients with gastroparesis who have failed or suffered adverse effects from standard medical therapy.

Detailed Summary:
Sponsor: Yale University

Current Primary Outcome: Improvement in Gastroparesis Cardinal Symptom Index [ Time Frame: upon study completion ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Yale University

Dates:
Date Received: September 24, 2008
Date Started: October 2008
Date Completion:
Last Updated: June 21, 2016
Last Verified: June 2016